The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Please provide your email address to receive an email when new articles are posted on . Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke ...

MOUNTAIN VIEW, Calif., Nov. 12, 2018 /PRNewswire/ -- AliveCor, the leader in artificial intelligence and FDA-cleared personal electrocardiogram (ECG) technology, today announced new medical research ...

July 14--A device a fraction of an inch long is providing George Saenz with a peace of mind he has never had before. Three weeks ago, the 67-year-old independent insurance agent had the Medtronic ...

Please provide your email address to receive an email when new articles are posted on . However, among patients with non-STEMI, those who received the implantable loop recorder (BioMonitor 2, ...

Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...